High somatic mutation and neoantigen burden do not correlate with decreased progression-free survival in hcc patients not undergoing immunotherapy

Angela Mauriello, Roberta Zeuli, Beatrice Cavalluzzo, Annacarmen Petrizzo, Maria Lina Tornesello, Franco M. Buonaguro, Michele Ceccarelli, Maria Tagliamonte, Luigi Buonaguro

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'High somatic mutation and neoantigen burden do not correlate with decreased progression-free survival in hcc patients not undergoing immunotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences